DSV A/S (VIE:DSV)

Intra-Cellular Therapies Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 5, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	44,961	48,092	33,279	32,016	48,107	30,995
Market Cap Growth	61.55%	44.51%	3.94%	-33.45%	55.21%	31.91%
Enterprise Value	57,325	53,080	37,538	35,674	51,748	33,234
Last Close Price	190.80	204.24	158.26	145.14	201.89	135.79
PE Ratio	33.01	35.48	20.14	13.56	31.92	54.28
PS Ratio	1.75	2.15	1.65	1.01	1.96	1.99
PB Ratio	2.94	3.13	3.60	3.32	4.82	4.88
P/TBV Ratio	-	9.88	-	-	-	-
P/FCF Ratio	22.50	37.52	17.19	9.40	32.45	25.20
P/OCF Ratio	20.04	30.78	15.07	8.87	29.31	22.45
EV/Sales Ratio	2.24	2.37	1.86	1.13	2.11	2.13
EV/EBITDA Ratio	18.40	23.16	15.02	10.09	22.58	24.20
EV/EBIT Ratio	25.36	24.66	15.83	10.54	23.74	26.03
EV/FCF Ratio	28.69	41.41	19.39	10.48	34.91	27.02
Debt / Equity Ratio	0.95	0.72	0.58	0.54	0.50	0.45
Debt / EBITDA Ratio	4.65	3.85	1.77	1.30	1.82	1.60
Debt / FCF Ratio	7.25	8.66	2.78	1.54	3.34	2.31
Asset Turnover	0.84	0.87	0.99	1.47	1.42	1.20
Inventory Turnover	26.30	26.64	34.49	168.91	169.23	63.56
Quick Ratio	0.91	3.10	0.99	1.12	1.10	1.00
Current Ratio	0.96	3.23	1.11	1.16	1.10	1.05
Return on Equity (ROE)	11.06%	11.09%	17.64%	24.20%	18.51%	8.81%
Return on Assets (ROA)	4.62%	5.23%	7.22%	9.82%	7.86%	6.13%
Return on Capital (ROIC)	6.22%	6.55%	10.05%	14.20%	11.29%	8.59%
Return on Capital Employed (ROCE)	8.20%	8.10%	16.30%	22.40%	15.00%	14.20%
Earnings Yield	3.03%	2.82%	4.96%	7.38%	3.13%	1.84%
FCF Yield	4.44%	2.67%	5.82%	10.64%	3.08%	3.97%
Dividend Yield	0.49%	0.46%	0.59%	0.60%	0.37%	0.40%
Payout Ratio	16.56%	15.17%	11.56%	7.51%	8.21%	13.84%
Buyback Yield / Dilution	-8.49%	0.16%	6.49%	0.93%	-0.46%	-14.98%
Total Shareholder Return	-8.00%	0.62%	7.08%	1.54%	-0.09%	-14.58%

Updated Feb 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.